ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
PORTLAND, Maine, May 14, 2020 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (the “Company” or “ImmuCell”), a growing animal health company […]
BASi Releases Earnings for Second Quarter of Fiscal 2020
WEST LAFAYETTE, Ind., May 14, 2020 (GLOBE NEWSWIRE) — Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We” or “Our”), doing […]
TRACON Pharmaceuticals Announces Presentation of Positive Clinical Data for Envafolimab in MSI-H/dMMR Cancer at ASCO 2020 Virtual Scientific Program by its Corporate Partners 3D Medicines and Alphamab
Envafolimab Demonstrated a 30% Confirmed Objective Response Rate (ORR) by RECIST by Independent Central Review in Patients with Advanced Refractory […]
Marrone Bio Innovations’ REGALIA® MAXX Receives First Approval for Use on Cannabis and Hemp in Canada
DAVIS, Calif., May 14, 2020 (GLOBE NEWSWIRE) — Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable […]
EHang to Participate in the 15th Annual Needham Virtual Technology & Media Conference on May 19-20, 2020
GUANGZHOU, China, May 14, 2020 (GLOBE NEWSWIRE) — EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), the world’s leading […]
LIZHI INC. to Participate in Upcoming Virtual Conferences
GUANGZHOU, China, May 14, 2020 (GLOBE NEWSWIRE) — LIZHI INC. (“LIZHI” or the “Company”) (NASDAQ: LIZI), a leading online UGC […]
CSP Inc. Reports Fiscal Year 2020 Second Quarter Financial Results
LOWELL, Mass., May 14, 2020 (GLOBE NEWSWIRE) — CSP Inc. (NASDAQ: CSPI), a provider of security and packet capture products, managed […]
ViralClear Publishes in F1000 Research In Vitro Data Demonstrating Synergy between Merimepodib and Remdesivir Against SARS-CoV-2, the Cause of COVID-19
Westport, CT, May 14, 2020 (GLOBE NEWSWIRE) —Merimepodib in combination with remdesivir decreases viral production of SARS-CoV-2 to undetectable levels […]
PetIQ, Inc. Announces Proposed Convertible Senior Notes Offering to Fund Capstar Acquisition
EAGLE, Idaho, May 14, 2020 (GLOBE NEWSWIRE) — PetIQ, Inc. (“PetIQ”) (NasdaqGS: PETQ) today announced its intention to offer, subject […]
Advaxis Announces Updated Positive Clinical and Biomarker Data from Ongoing Phase 1/2 ADXS-503 Trial in NSCLC
Sustained clinical benefit seen in patients treated with ADXS-503 in combination with KEYTRUDA® after 16 weeks, including a partial response […]
